Day, D.; Starus, A.; Gebski, V.; Simes, J.; Hayes, T.; Padinharakam, S.; Strickland, A.H.; Briscoe, K.; Varma, S.; Barnet, M.; Jackson, C.; Horvath, L.G.; Price, T.J.; Tebbutt, N.; Karki, B.; Diakos, C.I.; Chia, J.; Toh, H.C.; Jones, F.S. and Segelov, Eva (October 2023). 586P Minimal residual disease (MRD) detection using a tumour naïve circulating tumour DNA (ctDNA) assay in patients (pts) with resected colorectal cancer (CRC) in the phase III ASCOLT trial. Annals of oncology, 34(Suppl 2), S426-S427. Oxford University Press 10.1016/j.annonc.2023.09.1777
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Day_AnnOncol_2023_abstract.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (157kB) |
Item Type: |
Conference or Workshop Item (Abstract) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR) |
UniBE Contributor: |
Segelov, Eva |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Doris Kopp Heim |
Date Deposited: |
02 Nov 2023 11:37 |
Last Modified: |
20 Feb 2024 14:15 |
Publisher DOI: |
10.1016/j.annonc.2023.09.1777 |
BORIS DOI: |
10.48350/188508 |
URI: |
https://boris.unibe.ch/id/eprint/188508 |
Actions (login required)
 |
Edit item |